| ORAI1 — Calcium Release-Activated Calcium Channel Protein 1 | |
|---|---|
| Symbol | ORAI1 |
| Full Name | Calcium Release-Activated Calcium Channel Protein 1 |
| Chromosome | 12q24.31 |
| NCBI Gene | 84876 |
| Ensembl | ENSG00000182578 |
| OMIM | 610277 |
| UniProt | Q8WTG4 |
| Protein Length | 329 amino acids |
| Molecular Weight | ~33 kDa |
| Diseases | [Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Immunodeficiency, Stroke |
| Expression | T cells, Mast cells, Neurons, Astrocytes, Platelets |
ORAI1 encodes the pore-forming subunit of the calcium release-activated calcium (CRAC) channel, the primary pathway for store-operated calcium entry (SOCE) in eukaryotic cells. This channel represents the critical effector of the store-operated signaling pathway, responding to depletion of endoplasmic reticulum (ER) calcium stores by mediating rapid calcium influx across the plasma membrane. First identified through studies of patients with severe combined immunodeficiency (SCID), ORAI1 has since been recognized as a crucial regulator of calcium signaling in numerous cell types, including neurons, astrocytes, and immune cells[1].
The discovery of ORAI1 represents one of the most significant breakthroughs in calcium signaling research of the past two decades. Before its identification, the molecular identity of the CRAC channel had remained elusive for over 30 years despite extensive research efforts. The protein takes its name from the Greek word "ora" (mouth), reflecting its function as the channel that literally forms the mouth-like opening through which calcium enters the cell following ER calcium depletion[2].
In neurons, CRAC channels formed by ORAI1 (in combination with ORAI2 and ORAI3) play critical roles in synaptic plasticity, gene expression, and cellular survival. The close functional relationship between ORAI1 and its activator STIM1 creates a sophisticated calcium signaling system that responds dynamically to neuronal activity and pathological challenges.
The ORAI1 gene is located on chromosome 12q24.31 and contains 4 coding exons. Alternative splicing produces multiple transcript variants with differential expression patterns. The promoter contains binding sites for NFAT, AP-1, and other activity-dependent transcription factors, enabling rapid transcriptional regulation in response to calcium signaling.
ORAI1 exhibits broad but distinct expression patterns:
In the central nervous system, ORAI1 is expressed in both excitatory and inhibitory neurons, with particularly high levels in hippocampal CA1 pyramidal cells and cortical layer 2/3 neurons[3].
ORAI1 is a small transmembrane protein with unique structural features:
The activation of ORAI1 follows a precisely orchestrated sequence:
This mechanism provides highly localized Ca2+ signals that precisely match cellular demands.
ORAI1 channels exhibit distinctive biophysical properties:
CRAC channels contribute to AD pathophysiology through multiple mechanisms:
In dopaminergic neurons, ORAI1 plays complex roles:
Following cerebral ischemia, ORAI1 contributes to secondary neuronal injury:
ORAI1 plays a central role in neuroinflammatory processes:
| Strategy | Compound | Status | Mechanism |
|---|---|---|---|
| ORAI1 inhibitors | YM-58483 | Preclinical | Block CRAC channel pore |
| STIM1-ORAI1 disruptors | Synta66 | Research | Prevent coupling |
| Gene therapy | siRNA | Preclinical | Reduce ORAI1 expression |
ORAI1 interacts with:
Stathopulos PB, et al. STIM proteins and ORAI channels in calcium signaling (2019). Trends in Pharmacological Sciences. 2019. ↩︎
Prakriya M, et al. Store-operated calcium channels (2020). Trends in Neurosciences. 2020. ↩︎
Zhang W, et al. STIM1 and ORAI1 in neuronal development (2019). Neuroscience. 2019. ↩︎
Korkuat M, et al. STIM-ORAI signaling in Alzheimer's disease (2020). Neuroscience. 2020. ↩︎
Wang Y, et al. ORAI1 in Parkinson's disease models (2019). Movement Disorders. 2019. ↩︎